Viral Vectors
Backbone of Innovation: How CDMO Vector Platforms Are Accelerating Gene Therapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-09Jul 21, 2025
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734Dec 20, 2021
Cell and Gene Therapy
Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products
Jennifer Cheung
WuXi Advanced Therapies
PAO-09-21-CL-07Sep 14, 2021
Cell and Gene Therapy
Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies
David Y. H. Chang, Ph.D.
WuXi Advanced Therapies
PAO-05-21-CL-05May 27, 2021
AAV Platform Technologies
Increasing Predictability with AAV Platform Technologies
Felix Hsu
WuXi Advanced Therapies
PAP-Q4-20-CL-027Dec 09, 2020
Capacity Expansion
WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-the-Art Testing Laboratory
WuXi AppTec
PR-M11-20-019Nov 19, 2020
Expanded Services
WuXi Advanced Therapies Expands Services to Include High-Quality and Cost-Effective R&D and GMP Plasmid DNA
WuXi AppTec
PR-M11-20-011Nov 12, 2020
CAR-T Cell Therapy
WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
WuXi Advanced Therapies
PR-M05-20-NI-025May 18, 2020
AAV
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform
WuXi Advanced Therapies
PR-M01-20-NI-017Jan 13, 2020
Strategic Partnership
TrakCel Announces Strategic Partnership with WuXi AppTec Advanced Therapies for Optimization of Supply Chain for Cell and Gene Therapy Treatments
WuXi AppTec
PR-M10-19-NI-008-2078Oct 01, 2019
Cell and Gene Therapy
Driving Growth of the Cell and Gene Therapy Sector
Felix Hsu
WuXi Advanced Therapies
PAP-Q1-2019-CL-012Mar 12, 2019